Printer Friendly
The Free Library
14,735,889 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse DNA topic

Health aspects subtopic

 

Articles

1-32 out of 32 article(s)
Title Author Type Date Words
District & committee annual summary. Interview Dec 1, 2009 3272
Salivary molecular DNA testing and its impact on dental hygiene. Boucher-Bessent, Sandra Nov 1, 2009 1210
Enabling Capabilities of Inovio Biomedical's Electroporation Delivery Technology with SIV DNA Vaccine Confirmed in Collaborative Study With National Cancer Institute. Report Sep 3, 2009 1227
BLAME IT ON YOUR DNA. Aug 25, 2009 1060
Study results on DNA vs. Pap tests. Brief article May 1, 2009 131
VGX Pharmaceuticals Proprietary DNA Vaccines Delivered with Electroporation Achieve Immune Responses Superior to Recombinant Adenovirus Serotype 5 (Ad5) Vectors. Feb 18, 2009 600
Abnormal genes in DNA repair may help predict pancreatic cancer risk. Jan 15, 2009 530
Inovio Biomedical's Advances in Electroporation-Delivered Therapeutic Vaccines Presented at International DNA Vaccine Conference. Conference news Dec 17, 2008 1290
Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7%. Clinical report Nov 17, 2008 874
Metagenomic diagnosis of bacterial infections. Nakamura, Shota; Maeda, Norihiro; Miron, Ionut Mihai; Yoh, Myonsun; Izutsu, Kaori; Kataoka, Chidoh; Nov 1, 2008 2030
United States: NHGRI Seeks DNA Sequencing Technologies Fit for Routine Laboratory and Medical Use. Aug 21, 2008 359
The DNA Repair Company Licenses Test Predictive of Poor Outcomes to Breast Cancer Therapy. Jul 15, 2008 602
VGX Pharmaceuticals receives FDA approval of IND for novel DNA vaccine for cervical cancer therapy. Jul 1, 2008 277
Therapeutic DNA Vaccine Company Inovio Biomedical Presenting at BIO International. Jun 17, 2008 538
Reduced Hepatitis C Viral Level Achieved with DNA Vaccine Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study. Jun 4, 2008 813
Therapeutic DNA Vaccine Company Inovio Biomedical to Present at Upcoming Scientific Conferences. Conference news May 20, 2008 485
VGX Pharmaceuticals announces filings of two separate INDs covering novel DNA vaccines: one for cervical cancer therapy (VGX-3100) and one for avian influenza (VGX-3400). Clinical report May 19, 2008 588
Therapeutic Vaccine Company Inovio Biomedical Demonstrates Utility of Its Electroporation Delivery Technology as Potent Vaccine Adjuvant. Apr 9, 2008 976
ProNAi Therapeutics, Inc. Cleared to Begin Phase I Clinical Trials for the First DNA Interference (DNAi(R)) Therapeutic. Mar 20, 2008 510
Hepatitis C Virus DNA Vaccine Shows Safety When Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study at Karolinska University Hospital. Mar 17, 2008 1238
VGX Pharmaceuticals Announces the IND Filing of VGX-3200, a Novel DNA Therapy That Utilizes GHRH for the Treatment of Cancer Cachexia and Anemia. Clinical report Feb 8, 2008 362
Therapeutic DNA Vaccine Company, Inovio Biomedical, Promotes Punit Dhillon to Vice President of Finance & Operations. Jan 30, 2008 676
Therapeutic DNA Vaccine Delivery via Inovio's Electroporation Technology Featured in Nature Reviews Cancer. Jan 30, 2008 786
Therapeutic DNA Vaccine Company Inovio Biomedical Corp. Announces 'Clinical Trials Update' Conference Call on Jan. 29. Jan 24, 2008 599
Inovio Biomedical Partner Tripep Treats First Subject in Phase I/II Study of Novel Hepatitis C DNA Vaccine. Nov 27, 2007 1468
Genetic diversity of Bartonella henselae in human infection detected with multispacer typing. Li, Wenjun; Raoult, Didier; Fournier, Pierre-Edouard Aug 1, 2007 4728
Cryptosporidium hominis infection of the human respiratory tract. Ozaki, Luiz Shozo Mar 1, 2007 1754
Arsenic exposure is associated with decreased DNA repair in vitro and in individuals exposed to drinking water arsenic. Karagas, Margaret R. Aug 1, 2006 6390
DNA FOR SMALLPOX VIRUS AVAILABLE ON THE INTERNET. Jun 15, 2006 549
PowderMed's Therapeutic DNA Vaccine for Chronic Hepatitis B Enters Phase I Clinical Trials in Patients. Mar 29, 2006 1212
Compugen Announces In-Silico Protein Discovery from ''Junk DNA''; Findings Published in Proceedings of the National Academy of Sciences; Methodology has Enabled Discovery of Novel Therapeutic Protein Candidates. Feb 14, 2006 660
Cancer risk linked to increased DNA mix-ups. Pennisi, Elizabeth Jun 5, 1993 853

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles